Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3762479011 | Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3762480014 | Estradiol 312.5 nanogram/hour prolonged-release vaginal ring | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 46715701000001110 | Estradiol 2mg vaginal ring | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Is a | Product containing estradiol in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has active ingredient | Estradiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Is a | Product containing estradiol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Is a | Product containing estradiol in vaginal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Vaginal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Prolonged-release vaginal ring | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has basis of strength substance | Estradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has concentration strength denominator unit | hour | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has precise active ingredient | Estradiol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Is a | Product containing only estradiol in vaginal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has concentration strength numerator value | 312.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has concentration strength numerator unit | nanogram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Prolonged-release vaginal ring | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Vaginal route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | ring.vaginal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Vaginal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Is a | Estradiol | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Vaginal device | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Prolonged-release vaginal ring | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Prolonged-release vaginal ring | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Vaginal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Vaginal device | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Vaginal device | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has specific active ingredient | Estradiol | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has dispensed dose form | Vaginal device | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Has manufactured dose form | Vaginal device | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Estradiol 2mg(7.5micrograms/24hours) vaginal ring - product | Is a | False | Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Estring 2mg vaginal ring (Pfizer Ltd) | Is a | True | Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Estradiol 2mg vaginal ring 1 device | Is pack of | False | Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Estradiol 2mg vaginal ring 1 device | Has VMP | True | Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR